Prognostic Significance of Preoperative Integrated Liver Inflammatory Score in Patients with Hepatocellular Carcinoma

Biao Wu; Yumeng Wu; Xianlin Guo; Yifei Liu; Yanping Yue; Wenjing Zhao; Jibin Liu; Xuming Wu; Aiguo Shen; Suqing Zhang

doi:10.12659/MSM.937005

21 June 2022 : Clinical Research

Prognostic Significance of Preoperative Integrated Liver Inflammatory Score in Patients with Hepatocellular Carcinoma

Biao Wu^12ABCDEF, Yumeng Wu

^2ABC, Xianlin Guo^12BCF, Yifei Liu^3ACD, Yanping Yue^2BCF, Wenjing Zhao^2ABG, Jibin Liu^2ADG, Xuming Wu^4ABC, Aiguo Shen^2ACEG*, Suqing Zhang^1ACEFG

DOI: 10.12659/MSM.937005

Med Sci Monit 2022; 28:e937005

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 2 ILIS ROC curves of HCC patients. (A) The AUC of ILIS in the training cohort was 0.59. (B) The AUC of ILIS in the validation cohort was 0.60.

Back to the Article

Prognostic Significance of Preoperative Integrated Liver Inflammatory Score in Patients with Hepatocellular Carcinoma

Your Privacy